Which pricing strategy is specifically designed for medications that treat rare diseases affecting fewer than 200,000 patients in the US and often results in some of the highest-priced drugs on the market?

The pharmaceutical industry employs various pricing strategies based on market conditions, research costs, and target patient populations. One particularly notable approach is used for medications treating rare diseases. Test your knowledge about this specialized pricing strategy that has significant implications for both patients with rare conditions and healthcare systems worldwide. This pricing model has sparked debates about innovation incentives versus healthcare affordability.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Orphan Drug Pricing
Value-Based Pricing
Reference-Based Pricing
Cost-Plus Pricing